文献速递糖尿病

低剂量阿司匹林预防2型糖尿病患者痴呆效果的性别差异:一项随机临床试验的长期随访研究

Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial.
PubMed 文献 · Diabetes Care · 2019-12-04

本研究为日本JPAD试验的随访队列研究,纳入2536例2型糖尿病患者,随访至2017年,中位随访11.4年。低剂量阿司匹林对痴呆的总体预防效果不显著(HR 0.82,95%CI 0.58-1.16),但女性风险显著降低(HR 0.58,95%CI 0.36-0.95),男性无显著差异(HR 1.27,95%CI 0.75-2.13),交互作用P=0.03。

要点

  • 低剂量阿司匹林对2型糖尿病患者痴呆的总体预防效果不显著(HR 0.82,95%CI 0.58-1.16)。
  • 女性2型糖尿病患者使用低剂量阿司匹林与痴呆风险降低相关(HR 0.58,95%CI 0.36-0.95)。
  • 男性2型糖尿病患者使用低剂量阿司匹林与痴呆风险无显著关联(HR 1.27,95%CI 0.75-2.13),交互作用P=0.03。

核心结论

  • 长期使用低剂量阿司匹林可能降低女性2型糖尿病患者的痴呆风险。

研究设计与样本

  • 本研究为日本JPAD试验的随访队列研究,该试验为随机、开放标签、标准治疗对照试验,评估低剂量阿司匹林对心血管事件的影响。
  • 研究随访了2002年至2017年纳入JPAD试验的2536例日本2型糖尿病患者。
  • 本次事后分析的主要结局为痴呆发生率,定义为处方抗痴呆药物或因痴呆入院。

主要发现

  • 在最初纳入的患者中,有2121例(84%)保留了原始分组。
  • 中位随访11.4年期间,共有128例患者发生痴呆。
  • 校正年龄、性别及其他既定危险因素后,低剂量阿司匹林对痴呆的总体预防效果不显著(HR 0.82,95%CI 0.58-1.16)。
  • 女性中观察到痴呆风险显著降低(HR 0.58,95%CI 0.36-0.95),男性中无显著差异(HR 1.27,95%CI 0.75-2.13)(交互作用P=0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate and compare the efficacy of long-term use of low-dose aspirin for the prevention of dementia in men and women. RESEARCH DESIGN AND METHODS: This study is a follow-up cohort study of the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) trial, which was a randomized, open-label, standard care-controlled trial examining the effects of low-dose aspirin on cardiovascular events. We followed up 2,536 Japanese patients with type 2 diabetes (T2D) enrolled in the JPAD trial from 2002 to 2017. The primary outcome of this post hoc analysis was the incidence of dementia, which was defined by the prescription of antidementia drugs or admission due to dementia. RESULTS: Among the originally enrolled patients, 2,121 (84%) retained their original allocation. During a median follow-up of 11.4 years, 128 patients developed dementia. The overall effect of low-dose aspirin on the prevention of dementia adjusted for age, sex, and other established risk factors was not significant (hazard ratio [HR] 0.82, 95% CI 0.58-1.16). However, a significant reduction was seen in the risk of dementia in women (HR 0.58, 95% CI 0.36-0.95), but not in men (HR 1.27, 95% CI 0.75-2.13) (P interaction = 0.03). CONCLUSIONS: Long-term use of low-dose aspirin may reduce the risk for dementia in women with T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Matsumoto C, Ogawa H, Saito Y, et al. Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial. Diabetes Care. 2019. PMID: 31801787. doi:10.2337/dc19-1188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。